Search the Newsreel

Cineverse Launches VAUDIO™ to Help Brands Expand Audio Campaigns to CTV

Cineverse has launched VAUDIO™, a new ad tech offering that allows advertisers to adapt existing audio campaigns (podcast, radio, streaming) for Connected TV (CTV) by adding visuals, without needing traditional video production. This innovation aims to provide brands with an easy way to expand …

Is Cintas (CTAS) Fairly Valued On Its Leadership Reshuffle?

Cintas (CTAS) recently restructured its leadership, separating the President and CEO roles, with Jim Rozakis appointed President and COO. The company's stock shows positive short-term momentum despite a 1-year decline, though its P/E ratio is high compared to the industry. While Simply Wall St …

Cincinnati Financial Corp (CINF) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Cincinnati Financial Corp (CINF), detailing its current price momentum score, support and resistance levels, and indicator readings. It shows that CINF is currently suited for range-bound swing trading, with most indicators suggesting a "Sell" or "Neutral" position, …

Cinemark Keeps Quarterly Dividend at $0.09 per Share, Payable Sept. 9 to Holders of Record Aug. 26

Cinemark Holdings, Inc. announced it will maintain its quarterly dividend at $0.09 per share. This dividend is payable on September 9 to shareholders of record as of August 26. The company operates theaters in the United States and 13 countries across South and Central …

Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 12-Month High - Here's Why

Praxis Precision Medicines (NASDAQ:PRAX) recently hit a new 52-week high of $382.97, driven by positive analyst sentiment, including maintained "Buy" ratings and high price targets from HC Wainwright and RBC. The company beat quarterly EPS expectations and is anticipated to have significant catalysts in …

Revolution Medicines (RVMD) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Senior Vice President, Corporate Affairs - Ryan AsayChairman and Chief Executive Officer - Mark GoldsmithChief Development Officer - Alan SandlerChief Financial Officer - Jack AndersChief Medical Officer - …

National CineMedia to acquire Captivate Holdings, stock plunges

Handelsbanken Fonder AB Raises Stock Position in Revolution Medicines, Inc. $RVMD

Handelsbanken Fonder AB significantly increased its stake in Revolution Medicines, Inc. (NASDAQ:RVMD) by 243.6% in the second quarter, bringing its total holdings to 212,275 shares valued at $39.8 million. Despite institutional investors owning a substantial 94.34% of the company, Revolution Medicines reported a quarterly …

Cinemark Announces Quarterly Cash Dividend and Addition to Board of Directors

Cinemark Holdings, Inc. announced a quarterly cash dividend of $0.09 per share, payable on September 9, 2026, to stockholders of record on August 26, 2026. Additionally, Lawrence Burian has been appointed as a Class II Director to Cinemark's Board of Directors, expanding the board …

Cinevista Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Will Stronger Q2 2026 Results and a US$100.49 Million Buyback Change Cinemark Holdings' (CNK) Narrative

Cinemark Holdings (CNK) reported stronger Q2 2026 results with increased revenue and net income, alongside a US$100.49 million share buyback. These actions signal management confidence and aim to enhance shareholder returns by tightening the share count as profitability improves. Despite the positive short-term performance, …

National CineMedia, Inc. Stock 12‑Month Price Target Cut to $4.75, Implies 25% Upside

National CineMedia, Inc. (NCMI) has seen its average 12-month price target reduced from $5.20 to $4.75 by five analysts, with forecasts ranging from $4 to $6 per share. This new target suggests a potential upside of approximately 25% based on its recent closing price. …

Cinevista Q1 Results: Net profit rises 1%, revenue up 62% YoY

nCino (NCNO) Adds AI Mortgage Tools, Is The Stock Still Undervalued?

nCino (NCNO) has introduced new Model Context Protocol based AI tools into its Mortgage Suite, aiming to improve workflow efficiency for lenders. Despite recent positive share price momentum, the stock is down significantly over the past year. Analysts believe nCino is undervalued with a …

Revolution Medicines hits $44B market cap with breakthrough RAS cancer drugs, attracting big pharma interest.

Revolution Medicines has achieved a $44.1 billion market cap, driven by its promising RAS-targeting oncology pipeline, despite having no current product revenue. The company's drug, daraxonrasib, has shown strong clinical results, particularly in improving survival for pancreatic cancer patients. This success makes Revolution Medicines …

Why Revolution Medicines May Be Big Pharma’s Next Takeover Target

Revolution Medicines (NASDAQ:RVMD) is highlighted as a potential acquisition target for big pharma due to its strong late-stage RAS(ON) oncology pipeline, particularly daraxonrasib's impressive pancreatic cancer data. Merck (NYSE:MRK) is identified as the most likely acquirer, driven by the impending patent cliff for its …

Hotchkis & Wiley (NCMI) reports 9.45M National CineMedia shares under management

Hotchkis & Wiley Capital Management, LLC has reported beneficial ownership of 9,451,093 shares of National CineMedia, Inc. (NCMI), representing 10.08% of the outstanding common stock. The firm holds sole voting power over 8,113,552 shares and sole dispositive power over all 9,451,093 shares. This information …

Cinevista consolidated net profit rises 1.01% in the June 2026 quarter

Revolution Medicines (RVMD) Stock Looks Strong On Returns But Expensive On Value

Revolution Medicines (RVMD) has shown strong shareholder returns over the past five years, but its current valuation appears expensive based on broader checks. The stock trades at a high Price-to-Book ratio compared to its industry and peers, suggesting it may be overvalued despite excitement …

National CineMedia plummets after pausing dividend to help pay for acquisition

[Emerging Financial Data - Stock Market, Prosperity, Bull Market - Blue Version] DKosig National CineMedia (NCMI [https://seekingalpha.com/symbol/NCMI]) traded sharply lower in the premarket session after the cinema advertising company reported second quarter earnings below expectations. After a strong start to the third quarter with …

National CineMedia plummets after pausing dividend to help pay for acquisition (NCMI:NASDAQ)

National CineMedia (NCMI) experienced a sharp decline in premarket trading following its second-quarter earnings report, which fell below expectations. The cinema advertising company announced it is pausing its dividend to help fund an acquisition. This news contributed to the stock's significant drop.

National CineMedia Posts Downbeat Q2 Results, Joins Borr Drilling, AbCellera Biologics And Other Big Stoc

National CineMedia reported downbeat Q2 results, missing both analyst estimates for losses per share and sales, leading to a 16.4% dip in its shares in pre-market trading. Several other companies, including United States Antimony Corporation, Borr Drilling Limited, Absci Corporation, AbCellera Biologics Inc., Entravision …

Embracing Future Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2026

Tema ETFs LLC Sells 26,443 Shares of Revolution Medicines, Inc. $RVMD

Tema ETFs LLC has reduced its stake in Revolution Medicines, Inc. by 26.9%, selling 26,443 shares but still retaining 71,735 shares valued at $13.4 million. Despite this, institutional investors collectively own 94.34% of the company, and analyst sentiment remains largely positive with a "Moderate …

nCino sheds light on what’s fuelling financial crime in SA

nCino KYC highlights that fraud, corruption, state capture, and human trafficking are driving financial crime in South Africa, urging the financial services sector to leverage technology, including AI, to enhance defenses. The company emphasizes the critical role of advanced tech solutions like digital identity …

AIM Vaccine Sets August Board Meeting to Approve Interim Results and Consider Dividend

Q3 EPS Estimates for Prime Medicine Boosted by HC Wainwright

HC Wainwright has revised its Q3 2026 EPS estimate for Prime Medicine (NASDAQ: PRME) to a loss of $0.28 per share, a slight improvement from the previous forecast of $0.29. Despite maintaining a "Buy" rating and an $8.00 price target, analysts still anticipate the …

Revolution Medicines (RVMD) Stock Looks Rich On Fresh RAS Drug Demand

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Revolution Medicines has delivered a very large 5 year return that leaves the stock looking expensive on Simply Wall St's valuation checks. The current move …

Cineline India opens 3-screen Movie Max multiplex in Gurugram

Revolution Medicines’ 486% year leaves volume as the weak spot near the high

RVMD closed just 0.4% below its 52-week high after a 9.4% weekly gain, but participation remained light at 0.7x its 13-week average.

Vicinity Centres (ASX:VCX) Share Price Update Amid Real Estate Sector Pressure

National Cinemedia Inc (NCMI) Earnings Forecast: Future EPS & Revenue Growth Estimates

Revolution Medicines (RVMD) Is Up 6.2% After BeOne-Funded Phase 3 RAS(ON) Deal - Has The Bull Case Changed?

In early August 2026, BeOne Medicines Ltd. and Revolution Medicines, Inc. announced a multi-part collaboration combining BeOne's oncology assets with Revolution's four clinical RAS(ON) inhibitors, alongside a regional licensing deal granting BeOne exclusive development and commercialization rights in select Asian markets and responsibility for …

National CineMedia, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:NCMI) 2026-08-11

National CineMedia (NCMI) reported second-quarter 2026 revenue of $58.4 million, a 12.7% increase year-over-year, despite a net loss of $9.9 million. Following the earnings release, the company's shares rose 8.0% after market close, reflecting improved liquidity and operating cash flow. The article also details …

Revolution Medicines (RVMD) Looks Fairly Valued As BeOne Deal Expands Its Asia Reach

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Revolution Medicines (RVMD) just entered a comprehensive partnership with BeOne Medicines that combines joint clinical development work and a regional rights deal in …

Ncmi outlines Captivate deal financing with ~3.9x net leverage at close and pauses dividend

Earnings Call Insights: National CineMedia (NCMI) Q2 2026 MANAGEMENT VIEW * “NCM's announcement that the company has entered into a definitive agreement to acquire Captivate, the leading operator of digital video elevator and lobby advertising in North America.” (CEO & Director Thomas Lesinski) * …